Finance

Beta
Lists
338840:KOSDAQ
Y Biologics Inc
₩13,990.00
+3.25%
(+440.00) 1D
Jun 12, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 338840...
Open
₩14,060
High
₩14,440
Low
₩13,710
Mkt. cap
214.98B
Avg. vol.
144.25K
Volume
0.00
52-wk high
₩38,000
52-wk low
₩8,880
EPS
-₩2,965
Shares outstanding
15.37M
No. of employees
56
Open
₩14,060
High
₩14,440
Low
₩13,710
Mkt. cap
214.98B
Avg. vol.
144.25K
Volume
0.00
52-wk high
₩38,000
52-wk low
₩8,880
EPS
-₩2,965
Shares outstanding
15.37M
No. of employees
56
News stories
From sources across the web
About Y Biologics Inc
CEO-
Employees56
Founded2007
Headquarters-
SectorBiotechnology
Websiteybiologics.com
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.16B
892.40M
448.64M
281.89M
Cost of goods sold
124.78M
143.76M
102.10M
181.46M
Cost of revenue
124.78M
143.76M
102.10M
181.46M
Research and development expenses
-
-
2.08B
2.73B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.54B
3.28B
624.85M
1.02B
Operating expense
2.54B
3.28B
3.33B
3.98B
Total operating expenses
2.66B
3.42B
3.43B
4.16B
Operating income
-1.50B
-2.53B
-2.99B
-3.88B
Other non operating income
-840.07M
-163.95M
-31.50B
17.56M
EBT including unusual items
-2.34B
-2.69B
-35.11B
-4.32B
EBT excluding unusual items
-2.34B
-2.69B
-35.08B
-4.32B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
25.91M
28.69M
Net income
-2.34B
-2.69B
-35.11B
-4.32B
Net profit margin
-200.51%
-301.87%
-7,826.85%
-1,531.59%
Earnings per share
-
-
-
-
Interest and investment income
-
-
287.25M
248.03M
Interest expense
-
-
-884.15M
-855.57M
Net interest expenses
-
-
-596.90M
-607.54M
Depreciation and amortization charges
-
-
541.62M
156.84M
EBITDA
-1.01B
-2.07B
-2.48B
-3.35B
Gain or loss from assets sale
15.62M
-
16.93M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer